FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

15926711000001103: Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56380701000001112 Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
56380801000001115 Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Is a Irinotecan 100mg/5ml solution for injection vials 1 vial true Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Has AMP Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) true Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Has specific active ingredient Irinotecan hydrochloride trihydrate false Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Has specific active ingredient Irinotecan hydrochloride trihydrate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start